Drug Treatment

PreclinicalSmall molecule

BBiosense Webster, Inc.

Drug Treatment is one of 143 small molecule programs targeting Arrhythmia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

142

Competitors

Pipeline

Status by Indication[3][1]

Indication

ArrhythmiaActive, not recruiting

AdenomaActive, not recruiting

Bipolar DisorderActive, not recruiting

DermatomyositisActive, not recruiting

ImagingUnknown status

DepressionUnknown status

ArrhythmiaPreclinical

Active, not recruiting

AdenomaPreclinical

Active, not recruiting

Bipolar DisorderPreclinical

Active, not recruiting

DermatomyositisPreclinical

Active, not recruiting

ImagingPreclinical

Unknown status

DepressionPreclinical

Unknown status

Competition

Competitive Landscape

89 competitors in Bipolar Disorder

#DrugCompanyPhaseTrials

Tegretol

Novartis

Approved

1 2

Zofran

Novartis

Approved

1 3

Vyvanse

Vraylar

Keppra

Brintellix

Ritalin

Nolvadex

Zoloft

VViatris Specialty LLC

Approved

2 10

Haldol

DDePuy Orthopaedics

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

N/ARecruiting

Dermatomyositis

NCT07037472

Q3 2030

Not yet recruiting

Arrhythmia

NCT07123896

Clinical

Trials by Indication[1]

Systemic Sclerosis1 trial

Serial Night Time Position Splint on Systemic Sclerosis

Unknown status·FFederal University of São Paulo·Phase 3·NCT01586663·76 enrolled

Dermatomyositis1 trial

Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation

Recruiting·PPeking Union Medical College Hospital·N/A·NCT07037472·100 enrolled

Atrial Fibrillation1 trial

Atrial Fibrillation Progression Trial

Terminated·BBiosense Webster, Inc.·Phase 4·NCT01570361·255 enrolled

Adenoma1 trial

Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)

Unknown status·ZZhebao Wu·N/A·NCT03714763·50 enrolled

Ankylosing Spondylitis1 trial

Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study

Completed·UUniversity of Zurich·Phase 2·NCT01038011

6 more indications

Ventricular Tachycardia1 trial

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

Terminated·BBiosense Webster, Inc.·Phase 4·NCT01557842·15 enrolled

Bipolar Disorder1 trial

Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study

Unknown status·XXidian University·N/A·NCT03651674·200 enrolled

Imaging1 trial

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Unknown status·ZZhebao Wu·N/A·NCT03717454·50 enrolled

Arrhythmia1 trial

Arrhythmia Cohort Study

Not yet recruiting·—··NCT07123896·10,000 enrolled

MRI Scan1 trial

LiverMultiScan Analysis of MRI Scans in HCC

Completed·NNational Cancer Centre, Singapore··NCT04451603·21 enrolled

Depression1 trial

Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms

Unknown status·XXijing Hospital·N/A·NCT04037111·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for Drug Treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Drug Treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Drug Treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Biosense Webster, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: BBiosense Webster, Inc.

Drug Treatment

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Q3 2030

Trials by Indication[1]

Systemic Sclerosis1 trial

Dermatomyositis1 trial

Atrial Fibrillation1 trial

Adenoma1 trial

Ankylosing Spondylitis1 trial

Ventricular Tachycardia1 trial

Bipolar Disorder1 trial

Imaging1 trial

Arrhythmia1 trial

MRI Scan1 trial

Depression1 trial

References

Drug Info

Quick Facts

Related News